Rottendorf Pharma is participating in CPHI Milan this October at Booth 6N1 in Oelde.

A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 95 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients'​ organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers'​ benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.